NM_032119.4:c.2261T>C
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_032119.4(ADGRV1):c.2261T>C(p.Val754Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000868 in 1,613,274 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V754V) has been classified as Likely benign.
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 2CInheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- febrile seizures, familial, 4Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| ADGRV1 | ENST00000405460.9 | c.2261T>C | p.Val754Ala | missense_variant | Exon 12 of 90 | 1 | NM_032119.4 | ENSP00000384582.2 | ||
| ADGRV1 | ENST00000504142.2 | n.1027T>C | non_coding_transcript_exon_variant | Exon 6 of 14 | 5 | |||||
| ADGRV1 | ENST00000640403.1 | c.-437T>C | 5_prime_UTR_variant | Exon 2 of 29 | 5 | ENSP00000492531.1 | ||||
| ADGRV1 | ENST00000639676.1 | n.-235T>C | upstream_gene_variant | 5 | 
Frequencies
GnomAD3 genomes  0.0000657  AC: 10AN: 152158Hom.:  1  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.000141  AC: 35AN: 248760 AF XY:  0.000207   show subpopulations 
GnomAD4 exome  AF:  0.0000890  AC: 130AN: 1461116Hom.:  3  Cov.: 32 AF XY:  0.000125  AC XY: 91AN XY: 726816 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000657  AC: 10AN: 152158Hom.:  1  Cov.: 33 AF XY:  0.000108  AC XY: 8AN XY: 74324 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
The Val754Ala variant in GPR98 has not been previously reported in individuals w ith hearing loss, but has been identified in 0.03% (2/8154) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu /EVS/; dbSNP rs374609813). Although this variant has been seen in the general po pulation, its frequency is not high enough to rule out a pathogenic role. Compu tational prediction tools and conservation analyses do not provide strong suppor t for or against an impact to the protein. In summary, the clinical significance of the Val754Ala variant is uncertain. -
Usher syndrome type 2    Uncertain:1 
- -
not provided    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at